One
of biggest advances in improving the control of canine epilepsy
in recent years has been the more widespread use of monitoring
of anticonvulsant levels. Since the introduction of Epiphen in
the UK a scheme has been run by Vetoquinol to reduce the costs
of sampling for serum phenobarbitone levels. The scheme has three
aims to:
| • |
Increase awareness of the significance of serum
level monitoring
of phenobarbitone |
| |
| • |
Assist
veterinary surgeons that use Epiphen to help
them optimise
control of epilepsy in their patients |
| |
| • |
Generate
data for subsequent review of
serum phenobarbitone levels |
|
